BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 14615490)

  • 1. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.
    Roh J; Chang CL; Bhalla A; Klein C; Hsu SY
    J Biol Chem; 2004 Feb; 279(8):7264-74. PubMed ID: 14615490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
    Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
    Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
    Kikumoto K; Katafuchi T; Minamino N
    Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional expression of heteromeric calcitonin gene-related peptide and adrenomedullin receptors in yeast.
    Miret JJ; Rakhilina L; Silverman L; Oehlen B
    J Biol Chem; 2002 Mar; 277(9):6881-7. PubMed ID: 11733510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines.
    Choksi T; Hay DL; Legon S; Poyner DR; Hagner S; Bloom SR; Smith DM
    Br J Pharmacol; 2002 Jul; 136(5):784-92. PubMed ID: 12086988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
    Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
    Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells.
    Aldecoa A; Gujer R; Fischer JA; Born W
    FEBS Lett; 2000 Apr; 471(2-3):156-60. PubMed ID: 10767413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequencing of a calcitonin receptor-like receptor in salmon Oncorhynchus gorbuscha. Functional studies using the human receptor activity-modifying proteins.
    Pidoux E; Cressent M
    Gene; 2002 Oct; 298(2):203-10. PubMed ID: 12426108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines.
    Wunder F; Rebmann A; Geerts A; Kalthof B
    Mol Pharmacol; 2008 Apr; 73(4):1235-43. PubMed ID: 18174292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.
    Kamitani S; Sakata T
    Biochim Biophys Acta; 2001 May; 1539(1-2):131-9. PubMed ID: 11389975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and characterization of mouse calcitonin gene-related peptide receptor.
    Miyauchi K; Tadotsu N; Hayashi T; Ono Y; Tokoyoda K; Tsujikawa K; Yamamoto H
    Neuropeptides; 2002 Feb; 36(1):22-33. PubMed ID: 12147211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
    Thota C; Gangula PR; Dong YL; Yallampalli C
    Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure.
    Cueille C; Pidoux E; de Vernejoul MC; Ventura-Clapier R; Garel JM
    Biochem Biophys Res Commun; 2002 Jun; 294(2):340-6. PubMed ID: 12051717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin/intermedin family peptides in vertebrates.
    Chang CL; Roh J; Hsu SY
    Peptides; 2004 Oct; 25(10):1633-42. PubMed ID: 15476930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor.
    Steiner S; Muff R; Gujer R; Fischer JA; Born W
    Biochemistry; 2002 Sep; 41(38):11398-404. PubMed ID: 12234182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
    Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
    Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
    Born W; Muff R; Fischer JA
    Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins.
    Born W; Fischer JA; Muff R
    Recept Channels; 2002; 8(3-4):201-9. PubMed ID: 12529937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor.
    Fraser NJ; Wise A; Brown J; McLatchie LM; Main MJ; Foord SM
    Mol Pharmacol; 1999 Jun; 55(6):1054-9. PubMed ID: 10347248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.